Rh(III)-catalyzed annulation of oxadiazolones with CF3-imidoyl sulfoxonium ylides: access to trifluoromethyl-substituted fused-dihydroisoquinolines

Abstract

A rhodium(III)-catalyzed redox-neutral C(sp2)–H bond activation and annulation of oxadiazolones and CF3-substituted imidoyl sulfoxonium ylides (TFISYs) has been developed. The cascade C(sp2)–H bond imidoylmethylation and subsequent intramolecular nucleophilic addition sequence might be involved in the transformation, providing a direct access to diverse trifluoromethyl and amino-containing fused-dihydroisoquinolines.

Supplementary files

Article information

Article type
Paper
Submitted
05 May 2025
Accepted
12 Jun 2025
First published
13 Jun 2025

Org. Biomol. Chem., 2025, Accepted Manuscript

Rh(III)-catalyzed annulation of oxadiazolones with CF3-imidoyl sulfoxonium ylides: access to trifluoromethyl-substituted fused-dihydroisoquinolines

S. Ling, Q. Chen and Z. Chen, Org. Biomol. Chem., 2025, Accepted Manuscript , DOI: 10.1039/D5OB00732A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements